Knockdown of OLR1 weakens glycolytic metabolism to repress colon cancer cell proliferation and chemoresistance by downregulating SULT2B1 via c-MYC

[1]  C. Di Natale,et al.  LOX-1 and cancer: an indissoluble liaison , 2021, Cancer Gene Therapy.

[2]  S. Maurya,et al.  Epigenetic Modifications of c-MYC: Role in Cancer Cell Reprogramming, Progression and Chemoresistance. , 2020, Seminars in cancer biology.

[3]  Zong-ru Jiang,et al.  Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52 , 2020, Acta Pharmacologica Sinica.

[4]  C. Shan,et al.  Ciclopirox activates PERK-dependent endoplasmic reticulum stress to drive cell death in colorectal cancer , 2020, Cell Death & Disease.

[5]  Zhao Yang,et al.  Nobiletin inhibits cell growth through restraining aerobic glycolysis via PKA‐CREB pathway in oral squamous cell carcinoma , 2020, Food science & nutrition.

[6]  Petra Grbčić,et al.  Sphingosine 1-Phosphate Signaling and Metabolism in Chemoprevention and Chemoresistance in Colon Cancer , 2020, Molecules.

[7]  Y. Hamamoto,et al.  Serum LOX-1 is a novel prognostic biomarker of colorectal cancer , 2020, International Journal of Clinical Oncology.

[8]  Lianfang Zheng,et al.  OLR1 Promotes Pancreatic Cancer Metastasis via Increased c-Myc Expression and Transcription of HMGA2 , 2020, Molecular Cancer Research.

[9]  X. Zong,et al.  Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis , 2020, Frontiers in Oncology.

[10]  Y. Ba,et al.  Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer , 2020, Molecular oncology.

[11]  A. Bishayee,et al.  Medicinal Plants in the Prevention and Treatment of Colon Cancer , 2019, Oxidative medicine and cellular longevity.

[12]  Shanshan Jiang,et al.  Oxidized low density lipoprotein receptor 1 promotes lung metastases of osteosarcomas through regulating the epithelial-mesenchymal transition , 2019, Journal of translational medicine.

[13]  Jing Liu,et al.  Downregulation of circDYNC1H1 exhibits inhibitor effect on cell proliferation and migration in hepatocellular carcinoma through miR‐140‐5p , 2019, Journal of cellular physiology.

[14]  R. Capuano,et al.  Targeting LOX-1 Inhibits Colorectal Cancer Metastasis in an Animal Model , 2019, Front. Oncol..

[15]  Xiaowo Wang,et al.  Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer , 2019, Journal of Hematology & Oncology.

[16]  Xihui Sheng,et al.  Comparative adipose transcriptome analysis digs out genes related to fat deposition in two pig breeds , 2019, Scientific Reports.

[17]  Jun Ma,et al.  A noncoding RNA LINC00504 interacts with c‐Myc to regulate tumor metabolism in colon cancer , 2019, Journal of cellular biochemistry.

[18]  Yongsheng Zhou,et al.  Exosomes derived from miR‐375‐overexpressing human adipose mesenchymal stem cells promote bone regeneration , 2019, Cell proliferation.

[19]  Yun Cui,et al.  LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc , 2019, Nature Communications.

[20]  B. Patel,et al.  Therapeutic opportunities in colon cancer: Focus on phosphodiesterase inhibitors. , 2019, Life sciences.

[21]  M. Sabbir.  Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1 , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[22]  É. Audet-Walsh,et al.  Functional genomic studies reveal the androgen receptor as a master regulator of cellular energy metabolism in prostate cancer , 2019, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  J. Huo,et al.  Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism , 2019, Experimental and therapeutic medicine.

[24]  ping wang,et al.  c-Myc maintains the self-renewal and chemoresistance properties of colon cancer stem cells , 2019, Oncology letters.

[25]  Mingfu Wang,et al.  Chemopreventive effects of some popular phytochemicals on human colon cancer: a review. , 2018, Food & function.

[26]  Lei Xu,et al.  Salvianolic acid B reverses multidrug resistance in nude mice bearing human colon cancer stem cells , 2018, Molecular medicine reports.

[27]  Meilin Wang,et al.  Association study of genetic variants in estrogen metabolic pathway genes and colorectal cancer risk and survival , 2018, Archives of Toxicology.

[28]  J. Meyerhardt,et al.  NCCN Guidelines Insights: Colon Cancer, Version 2.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[29]  Xu Sun,et al.  Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer , 2018, BMC Cancer.

[30]  Christina Wu.  Systemic Therapy for Colon Cancer. , 2017, Surgical oncology clinics of North America.

[31]  F. Gruber,et al.  OLR1 scavenger receptor knockdown affects mitotic gene expression but is dispensable for oxidized phospholipid- mediated stress signaling in SZ 95 sebocytes , 2017, Mechanisms of Ageing and Development.

[32]  X. Bu,et al.  Up-regulation of OLR1 expression by TBC1D3 through activation of TNFα/NF-κB pathway promotes the migration of human breast cancer cells. , 2017, Cancer letters.

[33]  Guohua Yang,et al.  Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression , 2017, Oncotarget.

[34]  Sharada H. Sharma,et al.  Terpenoids as anti‐colon cancer agents – A comprehensive review on its mechanistic perspectives , 2017, European journal of pharmacology.

[35]  T. He,et al.  Methylglyoxal suppresses human colon cancer cell lines and tumor growth in a mouse model by impairing glycolytic metabolism of cancer cells associated with down-regulation of c-Myc expression , 2016, Cancer biology & therapy.

[36]  L. Kwong,et al.  Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models , 2016, Oncotarget.

[37]  R. Capuano,et al.  The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancer , 2016, Oncotarget.

[38]  K. Struhl,et al.  A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. , 2010, Cancer cell.

[39]  Zhao-You Tang,et al.  Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin , 2010, BMC Cancer.

[40]  C. Falany,et al.  Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression , 2009, Breast Cancer Research and Treatment.

[41]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[42]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .